Distributor inventory
Fenofibrate 150 mg (as Fenofibrate) tablet/capsule
Treatment of high cholesterol and high triglycerides (dyslipidaemia, hypertriglyceridaemia); used to reduce risk of pancreatitis in severe hypertriglyceridaemia; adjunct to diet and lifestyle changes
Fenofibrate activates PPAR-α, increasing lipolysis and clearance of triglyceride-rich lipoproteins. It lowers triglycerides and VLDL, can increase HDL, and improves overall lipid profile.
Oral use. Take exactly as prescribed, usually once daily; swallow whole with water. Often taken with food (follow brand/doctor advice). Continue diet, exercise and weight control while on therapy.
Common side effects of LIPIGO A 150MG may include:
Not for use in severe kidney disease, active liver disease, gallbladder disease, or known hypersensitivity. Risk of myopathy/rhabdomyolysis increases with statins, in elderly, diabetes, hypothyroidism, or renal impairment—report unexplained muscle pain, tenderness or weakness. Monitor liver function and kidney function periodically. May increase risk of gallstones; stop if pancreatitis is suspected. Dose adjustment/avoid in renal impairment.
